Aktis Oncology Inc. Share Price AKTS
$31.76
▲
0.87
(2.82%)
Last updated on
Check the interactive Aktis Oncology Inc. Stock chart to analyse performance
Aktis Oncology, Inc. Common stock Key Stats
Check Aktis Oncology Inc. key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Aktis Oncology Inc. Stock including INR - Dollar returns
The Aktis Oncology Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Aktis Oncology Inc. investment value today
Current value as on today
Returns
(0%)
Returns from Aktis Oncology Inc. Stock
(0%)
Dollar Impact
(0%)
Indian investors sentiment towards Aktis Oncology Inc. Stock
Global Institutional Holdings in Aktis Oncology, Inc. Common stock
Name
Holdings %
MPM Oncology Impact Management LP
8.75%
EcoR1 Capital, LLC
8.73%
Blue Owl Capital Holdings LP
5.72%
Wellington Management Company LLP
4.19%
T. Rowe Price Investment Management,Inc.
3.84%
BlackRock Inc
3.82%
Analyst Recommendation on Aktis Oncology Inc. Stock
Buy
72%Buy
27%Hold
0%Sell
Based on 11 Wall street analysts offering stock ratings for Aktis Oncology Inc.(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Aktis Oncology Inc. Share Price Target
What analysts predicted
Upside of 6.66%
Target:
$33.88
Current:
$31.76
Aktis Oncology Inc. share price target is $33.88, a slight Upside of 6.66% compared to current price of $31.76 as per analysts' prediction.
Aktis Oncology Inc. Stock Insights
Price Movement
In the last 1 month, AKTS stock has moved up by 59.7%Increasing Revenue
Revenue is up for the last 4 quarters, 933.0K → 3.22M (in $), with an average increase of 33.4% per quarterDecreasing Net Profit
Netprofit is down for the last 5 quarters, -6.42M → -18.32M (in $), with an average decrease of 33.5% per quarter
Aktis Oncology Inc. Technicals Summary
Sell
Neutral
Buy
Aktis Oncology Inc. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Aktis Oncology, Inc. Common stock Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 59.68% | 41.79% | 41.79% | 958.67% | 197.94% |
 | 4.06% | -14.28% | 21.59% | -8.85% | 12.37% |
 | 21.55% | 141.59% | 416.06% | 604.02% | 501.91% |
 | 19.54% | 17.66% | 14.94% | 51.6% | 163.95% |
 | 3.01% | -21.38% | -3.5% | 62.42% | 79.37% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -1.6 | -0.29 | -0.16 | NA | 9.16 |
| 15.25 | 15.25 | 1.08 | 46.21 | 0.15 | 0.06 | 0.01 | 308.33 |
| NA | NA | NA | -8.05 | -0.77 | -0.38 | NA | 7.49 |
| 29.59 | 29.59 | 1.85 | 19.15 | 0.24 | 0.12 | NA | 76.18 |
| 75.8 | 75.8 | 0.52 | 9.42 | 0.9 | 0.1 | NA | 8.06 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $1.7B | 197.94% | NA | 0.0% |
| Buy | $65.5B | 12.37% | 15.25 | 29.65% |
| Buy | $39.9B | 501.91% | NA | 0.0% |
| Buy | $126.4B | 163.95% | 29.59 | 35.51% |
| Buy | $40.3B | 79.37% | 75.8 | 12.55% |
About Aktis Oncology, Inc. Common stock
Key Management of Aktis Oncology, Inc. Common stock
Important FAQs about investing in AKTS Stock from India :
What is Aktis Oncology Inc. share price today?
Aktis Oncology Inc. share price today is $31.76 as on at the close of the market. Aktis Oncology Inc. share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.
What is the 52 week high and 52 week low for Aktis Oncology Inc. share?
Aktis Oncology Inc. share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Aktis Oncology Inc. stock price today i.e. is closed at $31.76, lower by 0% versus the 52 week high.
How to invest in Aktis Oncology Inc. Stock (AKTS) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Aktis Oncology Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aktis Oncology Inc. Shares that will get you 0.0472 shares as per Aktis Oncology Inc. share price of $31.76 per share as on July 3, 2026 at 1:30 am IST.
What is the minimum amount required to buy Aktis Oncology Inc. Stock (AKTS) from India?
Indian investors can start investing in Aktis Oncology Inc. (AKTS) shares with as little as ₹95.3275 or $1 (as of July 04, 2026) using the INDmoney app.
For example: If you want to invest $10 or ₹953.27 in Aktis Oncology Inc. stock (as per the Rupee-Dollar exchange rate as on July 04, 2026).
Based on Aktis Oncology Inc. share’s latest price of $31.76 as on July 3, 2026 at 1:30 am IST, you will get 0.3149 shares of Aktis Oncology Inc.. Learn more about
fractional shares .
What are the returns that Aktis Oncology Inc. has given to Indian investors in the last 5 years?
Aktis Oncology Inc. stock has given 197.94% share price returns and 28.27% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
Conexeu Sciences Inc. Common Stock$10.86
+5.85%
- SpyGlass Pharma, Inc. Common Stock
$19.15
-1.64%
- Mobia Medical, Inc. Common Stock
$13.65
+3.72%
- Damora Therapeutics, Inc. Common Stock
$29.98
+10.67%
- Glass House Brands Inc.
$12.50
+1.46%
- Regentis Biomaterials Ltd.
$4.03
-11.82%
- Faeth Therapeutics, Inc. Common Stock
$22.92
-3.13%
- Avalyn Pharma Inc. Common Stock
$29.73
-1.46%
Accendra Health, Inc.$3.59
+0.28%